citalopram + naltrexone

Citalopram + naltrexone is a combination of two pharmaceutical agents used experimentally for the treatment of co-occurring alcohol dependence and major depression, as well as in research for pathological gambling with comorbid alcohol abuse or dependence. Citalopram is a selective serotonin reuptake inhibitor (SSRI) that increases serotonergic neurotransmission by inhibiting the sodium-dependent serotonin transporter, thereby elevating synaptic serotonin levels. Naltrexone is an opioid receptor antagonist that blocks mu-opioid receptors, reducing the rewarding effects of alcohol and blunting cravings. The rationale behind combining these drugs is to address both mood symptoms (via citalopram) and addictive behaviors/cravings (via naltrexone). Clinical trials have shown that while both drugs are generally well tolerated together, adding citalopram to naltrexone does not significantly improve outcomes over naltrexone alone in patients with co-occurring depression and alcohol dependence; however, some subgroups may experience marginal benefit[1][3][4]. This combination remains investigational.